| |
| |
|
| Insider
Information: |
Oliviero James F Iii |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
561,014 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$478,492 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
561,014 |
|
|
| Total
Value |
$478,492 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
15
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
15
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-15.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -810.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
Chief Financial Officer |
2015-07-06 |
209,406 |
2008-08-14 |
0 |
Premium* |
|
|
Checkpoint Therapeutics, Inc. |
CKPT |
CEO, President and Dir... |
2024-02-28 |
341,780 |
|
0 |
Premium* |
|
|
Nuvectis Pharma, Inc. |
NVCT |
Director |
2022-02-08 |
9,828 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2024-02-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,056 |
341,780 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2024-02-28 |
4 |
S |
$2.06 |
$12,142 |
D/D |
(5,894) |
350,836 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2024-02-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,950 |
356,730 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2024-02-01 |
4 |
S |
$2.01 |
$23,919 |
D/D |
(11,900) |
369,680 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2023-03-02 |
4 |
S |
$5.00 |
$27,415 |
D/D |
(5,483) |
144,090 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2023-02-27 |
4 |
S |
$4.65 |
$25,798 |
D/D |
(5,548) |
134,573 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2023-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
149,573 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2023-02-01 |
4 |
S |
$4.77 |
$48,945 |
D/D |
(10,261) |
182,121 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2023-01-10 |
4 |
S |
$6.75 |
$25,761 |
D/D |
(3,817) |
192,382 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-06-23 |
4 |
S |
$1.11 |
$16,650 |
D/D |
(15,000) |
2,562,003 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-06-22 |
4 |
S |
$1.09 |
$13,080 |
D/D |
(12,000) |
2,577,003 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-06-21 |
4 |
S |
$1.09 |
$22,890 |
D/D |
(21,000) |
2,589,003 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-06-17 |
4 |
S |
$1.09 |
$248,520 |
D/D |
(228,000) |
2,610,003 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-04-13 |
4 |
S |
$1.51 |
$32,100 |
D/D |
(21,258) |
2,838,003 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-04-05 |
4 |
S |
$1.77 |
$24,833 |
D/D |
(14,030) |
2,859,261 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-04-04 |
4 |
S |
$1.79 |
$154,572 |
D/D |
(86,353) |
2,873,291 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-02-24 |
4 |
D |
$1.85 |
$217,665 |
D/D |
(117,657) |
2,959,644 |
0 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Director |
– • – |
2022-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,828 |
|
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
455,000 |
3,608,210 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-01-30 |
4 |
D |
$2.46 |
$78,651 |
D/D |
(31,972) |
3,077,301 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-01-24 |
4 |
D |
$2.19 |
$313,468 |
D/D |
(143,136) |
3,109,273 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-01-06 |
4 |
D |
$2.77 |
$146,876 |
D/D |
(53,024) |
3,252,409 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-01-01 |
4 |
D |
$3.11 |
$941,636 |
D/D |
(302,777) |
3,305,433 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2021-02-05 |
4 |
S |
$3.42 |
$166,745 |
D/D |
(48,790) |
3,153,210 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2021-02-04 |
4 |
S |
$3.51 |
$245,525 |
D/D |
(70,000) |
3,202,000 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
